Search Within

Malin Lisa Hultcrantz

Formats
  1. Meeting Abstract (178)
  2. Journal Article (70)
  3. Research Letter (10)
  4. Guidelines (6)
  5. Correspondence (3)
  6. Review (3)
  7. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (271)
  2. Department of Medicine (271)
  3. Hematologic Malignancies, Division of (271)
  4. Myeloma (271)
  5. Sloan Kettering Institute Postdocs (271)
  6. Hematologic Malignancies Research (188)

More Groups

People
  1. Sham Mailankody (157)
  2. Neha Korde (154)
  3. Alexander Lesokhin (149)
  4. Hani Hassoun (143)
  5. Urvi Shah (134)
  6. Sergio Giralt (128)

More People

Years
  1. 2025 (12)
  2. 2024 (46)
  3. 2023 (51)
  4. 2022 (52)
  5. 2021 (30)
  6. 2020 (26)

More Years

Publications
  1. Blood (104)
  2. Clinical Lymphoma, Myeloma and Leukemia (50)
  3. Journal of Clinical Oncology (17)
  4. Blood Cancer Journal (14)
  5. Haematologica (10)
  6. Blood Advances (7)

More Publications

Publishers
  1. American Society of Hematology (111)
  2. Elsevier Inc. (56)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (10)
  6. American Association for Cancer Research (6)

More Publishers

Results (271)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma: DREAMM-14
    Meeting Abstract

    Hultcrantz, M.; Kleinman, D.; Ghataorhe, P.; McKeown, A.; He, W.; Ling, T.; Jewell, R. C.; Brunner, J.; Byrne, J.; Eliason, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world experience
    Meeting Abstract

    Hultcrantz, M.; Orozco, J.; Peterson, T. J.; Derkach, A.; Hassoun, H.; Korde, N.; Lu, S. X.; Mailankody, S.; Patel, D.; Shah, U. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and COVID-19: A population-based cohort study
    Journal Article

    Rognvaldsson, S.; Eythorsson, E.; Thorsteinsdottir, S.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; ThorsteinsdoĢttir, I.; Olafsson, I.; Runolfsdottir, H. L.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients
    Meeting Abstract

    Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplant: Interim analysis of the multicenter 2nd chance protocol
    Meeting Abstract

    Shah, G.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R.; Costa, L.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Disease- and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies
    Journal Article

    Chung, D. J.; Shah, G. L.; Devlin, S. M.; Ramanathan, L. V.; Doddi, S.; Pessin, M. S.; Hoover, E.; Marcello, L. T.; Young, J. C.; Boutemine, S. R.; more...
    Blood Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Belantamab mafodotin (belamaf; GSK2857916) US expanded access program (EAP) for heavily pre-treated patients with relapsed/refractory multiple myeloma (RRMM): Baseline characteristics
    Meeting Abstract

    Hultcrantz, M.; Anderson, L. D. Jr; Anwer, F.; Gasparetto, C.; Kocoglu, M. H.; Lichtman, E. I.; Mo, C.; Niesvizky, R.; Lewis, E.; Li, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
    Journal Article

    Maclachlan, K. H.; Rustad, E. H.; Derkach, A.; Zheng-Lin, B.; Yellapantula, V.; Diamond, B.; Hultcrantz, M.; Ziccheddu, B.; Boyle, E. M.; Blaney, P.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save